IRMD Company Profile and Key Details

Q: Who are the executives of IRMD?

Mr. Roger E. SusiFounder, Chairman, Chief Executive Officer & PresMr. Chris WilliamsonExecutive Vice President of Continuous Improvement & Information TechnologyMr. Matt GarnerControllerMr. Randy WaddellVice President of Worldwide Sales & MarketingMr. Steve KachelmeyerVice President of Regulatory Affairs & Quality AssuranceMr. Lynn NeuhardtVice President of R&DMr. John F. GlennChief Financial Officer & Corporation Sec.

NASDAQ : IRMD

IRadimed

$92.50

1.285+1.41%

At Close 4:00 PM

72.88

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

IRadimed Corporation (IRMD) stock surged +1.41%, trading at $92.50 on NASDAQ, up from the previous close of $91.21. The stock opened at $91.40, fluctuating between $91.40 and $93.04 in the recent session.

Stock Snapshot

91.21

Prev. Close

1.18B

Market Cap

91.4

Day Low

46.48

P/E Ratio

1.99

EPS (TTM)

0.43

Cash Flow per Share

91.4

Open

12.78M

Number of Shares

93.04

Day High

56.42%

Free Float in %

5.66

Book Value

87.46K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 07, 2026	91.40	93.04	91.40	92.50	88.2K
Aug 06, 2026	92.67	93.17	90.14	91.21	94.44K
Aug 05, 2026	92.90	93.59	91.27	91.86	148.48K
Aug 04, 2026	91.42	94.73	91.42	93.13	215.02K
Aug 03, 2026	92.95	94.77	89.70	91.56	214.72K
Jul 31, 2026	97.74	97.74	89.51	90.86	308.08K
Jul 30, 2026	94.25	95.65	93.98	95.21	122.19K
Jul 29, 2026	94.85	96.10	93.87	94.26	111.51K
Jul 28, 2026	96.08	96.77	93.55	94.83	113.77K
Jul 27, 2026	95.56	97.58	94.51	95.08	67.15K
Jul 24, 2026	94.69	96.02	94.22	94.49	79.66K
Jul 23, 2026	93.01	94.26	92.77	93.86	82.77K
Jul 22, 2026	94.75	96.68	93.50	94.08	91.87K
Jul 21, 2026	96.59	97.10	94.62	94.97	126.07K
Jul 20, 2026	97.29	98.46	96.14	97.03	75.92K
Jul 17, 2026	96.31	97.94	96.25	97.03	129.67K
Jul 16, 2026	93.97	98.61	93.97	97.77	97.39K
Jul 15, 2026	91.20	94.74	90.83	93.62	125.54K
Jul 14, 2026	97.25	97.46	91.57	91.67	176.01K
Jul 13, 2026	97.40	98.23	96.39	97.69	136.39K

Contact Details

Orlando, FL 32708

United States

https://www.iradimed.com 407 677 8022

About Company

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

2.14+0.69%

UFP Technologies, Inc.$314.01 MASI

Masimo Corporation$179.95 ALGN

4.58+2.71%

Align Technology, Inc.$173.66 PODD

1.87+1.34%

Insulet Corp.$141.17 IRTC

-0.28-0.22%

iRhythm Technologies, Inc.$127.84 DXCM

1.73+2.08%

DexCom, Inc.$84.75 TMDX

3.68+4.59%

TransMedics Group, Inc.$83.89 NARI

Inari Medical, Inc.$79.97 ESTA

-1.63-2.06%

Establishment Labs Holdings Inc.$77.42

Company Overview

IRadimed Corporation (NASDAQ:IRMD) closed at $92.50 USD, gaining $1.29 (1.41%) from the previous close of $91.21. The stock is currently mid-range between its 52-week high and low $67.84 and $107.90. With a market capitalization of about $1.18 billion, IRadimed Corporation is classified as a small-cap and shows market-like volatility (beta ~0.91). Key stats such as the average daily volume over the past year has been around 139.61 thousand shares, volume is running light vs its 52-week average. Headquartered in Orlando, FL, IRadimed Corporation operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Roger E. Susi, the company employs approximately 166 people and listed since July 16, 2014. IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments.

Technical Performance

IRMD has shown sold momentum, gaining 5.19% over the past week and 40.97% over the past quarter, though year-to-date performance is up 5.86%. Short-term trend indicators are bearishly aligned (SMA20 2.84%, SMA50 3.36%, SMA200 32.71%). The stock’s 14-day RSI is 55.73 (neutral), while the ATR of 3.39 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -5.08% below its high and over 116.84% above its low. Average 10-day trading volume of 162.83 thousand shares is slightly above the 3-month average of 137.11 thousand, indicating heightened recent market interest.

Valuation Metrics

IRadimed Corporation trades at a P/E ratio of 50.62, slightly above the S&P 500 average, with a price-to-sales ratio of 13.64 and a price-to-book ratio of 11.58 reflecting a rich premium to book value. The P/FCF stands at 47.24, also below market averages. Compared to sector medians, IRadimed Corporation P/S is trading rich, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

IRadimed Corporation last paid a dividend of 1.24 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $55.89. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

IRadimed Corporation generated EPS of $1.75 over the past year. Five-year average earnings growth is 73.91%. The latest quarter delivered EPS of $0.46. The next quarter is forecast at $0.45. Next year's EPS is expected at $15.28. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $116.00 to $116.00. The high target offers 25.41% upside. The low target suggests 25.41% downside. The mean target is $116.00. This offers 25.41% upside. IRadimed Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended July 31, 2026, missed forecasts by 4.55%. The prior quarter beat by 6.52%. Over the last six quarters, Apple has recorded several small beats. These include -2.33% in May 05, 2025.

Shareholding & Insider Activity

IRadimed Corporation has 12.78 million shares outstanding. The public float is 8.33 million shares, elevated short interest at 8.52% of float. This equals 705.83 thousand shares. The short ratio is 4.94 days. Institutional investors hold 94.53% of the float. Insiders own 35.2%. Susi Roger E. holds 2.16 million shares, HAWKINS JAMES B has 28.74 thousand shares and ALLEN MONTY K has 21.00 thousand shares. Over the past six months, insider transactions show net selling. They sold 29.73 thousand shares across 27 transactions.

Financial & Profitability Overview

Over the trailing twelve months, IRadimed generated $65.56M in revenue, or $5.15 per share. Gross margin was 76.50%, operating margin 30.56%, and net profit margin 26.22%. Returns are exceptional, with ROA at 18.66% and ROE at 24.07%.
On valuation metrics, IRadimed trades at a P/E of 50.62, P/S of 13.64 and P/B of 11.58. The current ratio is 9.46 and quick ratio is 9.46. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 23.38 days.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, IRadimed posted revenue of $65.56M, down slightly from $53.30M in the prior quarter. Gross profit was $50.16M (margin 76.50%). Operating income was $20.04M (margin 30.6%). Net income was$17.19M (EPS $1.36).
The company ended the quarter with $49.76M in cash and short-term investments, a total debt of $2.04M, and net debt of - $47.72M. Total assets were $92.16M, with equity of $71.42M. Financials further reflected stability, with operating cash flow of $13.47M, free cash flow of $5.46M, and capital expenditures of - $8.01M.

Price Forecast & Outlook

Our AI price prediction model suggests that IRadimed Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.53%, with price expected at $88.31 by August 21, 2026, within a range of $86.00 to $90.48 3-Month Outlook: Projected rise of 27.38%, reaching $117.83 by November 04, 2026, with a range of $115.89 to $120.03. 1-Year Outlook: Projected gain of 20.83%, with price at $111.77 by August 06, 2027, within a range of $107.96 to $115.40.

Key Takeaways

IRadimed Corporation (NASDAQ:IRMD) shares are flat 5.86% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows IRadimed Corporation trading at a premium to the broader market with a P/E of 50.62. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $45.44, suggesting -50.88% downside. Our AI forecast model points to short-term weakness (-4.53% over two weeks), a medium-term rise (27.38% over three months), and a longer-term gain (20.83% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current IRadimed Corporation (IRMD) stock price?

IRadimed Corporation (NASDAQ: IRMD) stock price is $92.50 in the last trading session. During the trading session, IRMD stock reached the peak price of $93.04 while $91.40 was the lowest point it dropped to. The percentage change in IRMD stock occurred in the recent session was 1.41% while the dollar amount for the price change in IRMD stock was $1.29.

IRMD's industry and sector of operation?

The NASDAQ listed IRMD is part of Medical - Devices industry that operates in the broader Healthcare sector. IRadimed Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IRMD?

Mr. Roger E. Susi
Founder, Chairman, Chief Executive Officer & Pres
Mr. Chris Williamson
Executive Vice President of Continuous Improvement & Information Technology
Mr. Matt Garner
Controller
Mr. Randy Waddell
Vice President of Worldwide Sales & Marketing
Mr. Steve Kachelmeyer
Vice President of Regulatory Affairs & Quality Assurance
Mr. Lynn Neuhardt
Vice President of R&D
Mr. John F. Glenn
Chief Financial Officer & Corporation Sec.

How IRMD did perform over past 52-week?

IRMD's closing price is 36.34% higher than its 52-week low of $67.84 where as its distance from 52-week high of $107.90 is -14.28%.

How many employees does IRMD have?

Number of IRMD employees currently stands at 166.

Link for IRMD official website?

Official Website of IRMD is: https://www.iradimed.com

How do I contact IRMD?

IRMD could be contacted at phone 407 677 8022 and can also be accessed through its website. IRMD operates from 1025 Willa Springs Drive, Orlando, FL 32708, United States.

How many shares of IRMD are traded daily?

IRMD stock volume for the day was 87.46K shares. The average number of IRMD shares traded daily for last 3 months was 139.61K.

What is the market cap of IRMD currently?

The market value of IRMD currently stands at $1.18B with its latest stock price at $92.50 and 12.78M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	166
Beta	0.91
Sales or Revenue	$65.56M
5Y Sales Change%	1.07%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

IRMD Company Profile and Key Details

IRadimed

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways